Ola Nilsson

机构：Karolinska University Hospital, Karolinska Institutet · ORCID：0000-0002-9986-8138

发表论文 630 篇 · 总被引 26236 次 · h-index 79

代表论文

• The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data (2023 · Orphanet Journal of Rare Diseases · 被引 50)
• REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage (2024 · Journal of neurosurgery · 被引 37)
• Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period (2024 · JBMR Plus · 被引 20)
• A Systematic Review of the Effects of Bisphosphonates on Osteoblasts In Vitro (2025 · Calcified Tissue International · 被引 10)
• PLS3 Mutations in X-Linked Osteoporosis: Clinical and Genetic Features in Five New Families (2023 · Calcified Tissue International · 被引 10)
• Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis (2024 · Therapeutic Advances in Chronic Disease · 被引 8)